in_the_media
Philadelphia Inquirer - November 12, 2010
Posted Nov 12, 2010 -- webcomm
Media Outlet:
Philadelphia Inquirer
Pharmaceutical companies once relied on their own research-and-development divisions to identify and deliver blockbuster medications. In recent years, that path has been unproductive. Albert Wertheimer of the School of Pharmacy said the industry now believes that R&D alone isn't the answer. "The takeaway message is you are better off buying the products from smaller companies or foreign companies that don't have marketing arms in the U.S.," he said.